Phase II study of cisplatin/etoposide and endostar for extensive-stage small-cell lung cancer.

Zheng-tao Zhou,Fu Xiang Zhou,Qing Wei,Li-yong Zou,Bin-fang Qin,Xu-shen Peng

Phase II study of cisplatin/etoposide and endostar for extensive-stage small-cell lung cancer.

2011

Zheng-tao Zhou
Fu Xiang Zhou
Qing Wei
Li-yong Zou
Bin-fang Qin
Xu-shen Peng

Purpose To investigate the efficacy and safety of endostar, a novel recombinant human endostatin, plus cisplatin, and etoposide in patients with extensive-stage small-cell lung cancer (ED-SCLC).

Keywords:

Etoposide
Recombinant Human Endostatin
Extensive-stage small cell lung cancer
Cisplatin
Pharmacology
Phases of clinical research
Cancer research
Lung cancer
Cisplatin/etoposide
Medicine
Chemotherapy
Survival rate

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations